These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 20194810)
1. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Ciarka A; Doan V; Velez-Roa S; Naeije R; van de Borne P Am J Respir Crit Care Med; 2010 Jun; 181(11):1269-75. PubMed ID: 20194810 [TBL] [Abstract][Full Text] [Related]
2. Increased sympathetic nerve activity in pulmonary artery hypertension. Velez-Roa S; Ciarka A; Najem B; Vachiery JL; Naeije R; van de Borne P Circulation; 2004 Sep; 110(10):1308-12. PubMed ID: 15337703 [TBL] [Abstract][Full Text] [Related]
3. Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension. McGowan CL; Swiston JS; Notarius CF; Mak S; Morris BL; Picton PE; Granton JT; Floras JS Heart; 2009 May; 95(9):754-8. PubMed ID: 19151012 [TBL] [Abstract][Full Text] [Related]
4. Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension. Ciarka A; Vachièry JL; Houssière A; Gujic M; Stoupel E; Velez-Roa S; Naeije R; van de Borne P Chest; 2007 Jun; 131(6):1831-7. PubMed ID: 17400672 [TBL] [Abstract][Full Text] [Related]
5. Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension. Minai OA; Gudavalli R; Mummadi S; Liu X; McCarthy K; Dweik RA Am J Respir Crit Care Med; 2012 Feb; 185(4):400-8. PubMed ID: 22108205 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. Benza RL; Gomberg-Maitland M; Naeije R; Arneson CP; Lang IM J Heart Lung Transplant; 2011 Sep; 30(9):982-9. PubMed ID: 21531577 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502 [TBL] [Abstract][Full Text] [Related]
8. Salt supresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives. Abrahão SB; Tinucci T; Santello JL; Mion D J Hum Hypertens; 2002 Dec; 16(12):843-50. PubMed ID: 12522465 [TBL] [Abstract][Full Text] [Related]
9. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure. Notarius CF; Butler GC; Ando S; Pollard MJ; Senn BL; Floras JS Clin Sci (Lond); 1999 Jun; 96(6):557-65. PubMed ID: 10334961 [TBL] [Abstract][Full Text] [Related]
11. Portopulmonary hypertension: survival and prognostic factors. Le Pavec J; Souza R; Herve P; Lebrec D; Savale L; Tcherakian C; Jaïs X; Yaïci A; Humbert M; Simonneau G; Sitbon O Am J Respir Crit Care Med; 2008 Sep; 178(6):637-43. PubMed ID: 18617641 [TBL] [Abstract][Full Text] [Related]
12. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012 [TBL] [Abstract][Full Text] [Related]
13. Heart rate recovery in pulmonary arterial hypertension: relationship with exercise capacity and prognosis. Ramos RP; Arakaki JS; Barbosa P; Treptow E; Valois FM; Ferreira EV; Nery LE; Neder JA Am Heart J; 2012 Apr; 163(4):580-8. PubMed ID: 22520523 [TBL] [Abstract][Full Text] [Related]
14. [Two years of multidisciplinary diagnostic and therapeutic experience in patients with pulmonary arterial hypertension]. Tokgözoğlu L; Akdoğan A; Okutucu S; Kaya EB; Aytemir K; Ozkutlu H Turk Kardiyol Dern Ars; 2009 Sep; 37(6):378-83. PubMed ID: 20019450 [TBL] [Abstract][Full Text] [Related]
15. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry. Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral. Badagliacca R; Pezzuto B; Poscia R; Mancone M; Papa S; Marcon S; Valli G; Sardella G; Ferrante F; Iacoboni C; Parola D; Fedele F; Vizza CD J Heart Lung Transplant; 2012 Apr; 31(4):364-72. PubMed ID: 22289484 [TBL] [Abstract][Full Text] [Related]
17. Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men. Hogarth AJ; Burns J; Mackintosh AF; Mary DA J Hum Hypertens; 2008 Aug; 22(8):544-9. PubMed ID: 18463670 [TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Richter MJ; Tiede H; Morty RE; Voswinckel R; Seeger W; Schulz R; Ghofrani HA; Reichenberger F Respiration; 2014; 88(1):24-30. PubMed ID: 24852295 [TBL] [Abstract][Full Text] [Related]
19. The sympathetic drive after acute myocardial infarction in hypertensive patients. Hogarth AJ; Mackintosh AF; Mary DA Am J Hypertens; 2006 Oct; 19(10):1070-6. PubMed ID: 17027830 [TBL] [Abstract][Full Text] [Related]
20. Smoking is associated with chronic sympathetic activation in hypertension. Hering D; Kucharska W; Kara T; Somers VK; Narkiewicz K Blood Press; 2010 Jun; 19(3):152-5. PubMed ID: 20429695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]